HIGHLIGHTS
- who: Yongchang Guo from the Department of Orthopedics, Zhengzhou Traditional Chinese Hospital of Orthopaedics, Zhengzhou, Henan, China have published the research: Analysis of the potential biological mechanisms of Danyu Gukang Pill against osteonecrosis of the femoral head based on network pharmacology, in the Journal: (JOURNAL)
- what: Combined with network pharmacology analysis molecular docking and in vitro cell experiments the study demonstrated that the treatment effect of DGP on ONFH might be closely related to the two targets HIF1A (HIF-1u03b1) and VEGFA and the HIF-1 signaling pathway. This study still has some limitations, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.